The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems
Open accessAbstract
Red blood cells (RBCs) constitute a unique drug delivery system as a biologic or hybrid carrier capable of greatly enhancing pharmacokinetics, altering pharmacodynamics (for example, by changing margination within the intravascular space), and modulating immune responses to appended cargoes. Strategies for RBC drug delivery systems include internal and surface loading, and the latter can be performed both ex vivo and in vivo. A relatively new avenue for RBC drug delivery is their application as a carrier for nanoparticles. Efforts are also being made to incorporate features of RBCs in nanocarriers to mimic their most useful aspects, such as long circulation and stealth features. RBCs have also recently been explored as carriers for the delivery of antigens for modulation of immune response. Therefore, RBC-based drug delivery systems represent supercarriers for a diverse array of biomedical interventions, and this is reflected by several industrial and academic efforts that are poised to enter the clinical realm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Self-citationThe Structure and Function of the Endothelial Glycocalyx Layer
Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151959 · Cited by 1,198
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
Red cell membrane: past, present, and future
Mohandas, N., & Gallagher, P. G. (2008) · Blood · doi:10.1182/blood-2008-07-161166 · Cited by 1,089
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
The Rh blood group system: a review
Avent, N. D., & Reid, M. E. (2000) · Blood · doi:10.1182/blood.v95.2.375 · Cited by 704
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Kolhar, P., Anselmo, A. C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308345110 · Cited by 646
Self-citationFearon, D. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.1.20 · Cited by 644
Cell membrane-camouflaged nanoparticles for drug delivery
Luk, B. T., & Zhang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.019 · Cited by 610
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells
Giarratana, M.-C., Kobari, L., Lapillonne, H., Chalmers, D., Kiger, L., Cynober, T., Marden, M. C., Wajcman, H., & Douay, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1047 · Cited by 574
Zhao, Y., Sun, X., Zhang, G., Trewyn, B. G., Slowing, I. I., & Lin, V. S.-Y. (2011) · ACS Nano · doi:10.1021/nn103077k · Cited by 572
Merkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
Self-citationAn overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Self-citationA Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Self-citationChou, S. T., Jackson, T., Vege, S., Smith-Whitley, K., Friedman, D. F., & Westhoff, C. M. (2013) · Blood · doi:10.1182/blood-2013-03-490623 · Cited by 490
Tsai, R. K., & Discher, D. E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708043 · Cited by 486
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Maldonado, R. A., LaMothe, R. A., Ferrari, J. D., Zhang, A.-H., Rossi, R. J., Kolte, P. N., Griset, A. P., O’Neil, C., Altreuter, D. H., Browning, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408686111 · Cited by 441
Piao, J.-G., Wang, L., Gao, F., You, Y.-Z., Xiong, Y., & Yang, L. (2014) · ACS Nano · doi:10.1021/nn503779d · Cited by 426
Drug delivery by red blood cells: vascular carriers designed by mother nature
Muzykantov, V. R. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003610633 · Cited by 399
Self-citationRed blood cell-mimicking synthetic biomaterial particles
Doshi, N., Zahr, A. S., Bhaskar, S., Lahann, J., & Mitragotri, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907127106 · Cited by 374
Self-citationAnselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355
Self-citationAnselmo, A. C., Modery-Pawlowski, C. L., Menegatti, S., Kumar, S., Vogus, D. R., Tian, L. L., Chen, M., Squires, T. M., Sen Gupta, A., & Mitragotri, S. (2014) · ACS Nano · doi:10.1021/nn503732m · Cited by 350
Self-citationProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
Nanoparticle-detained toxins for safe and effective vaccination
Hu, C.-M. J., Fang, R. H., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.254 · Cited by 342
Disorders of red cell membrane
An, X., & Mohandas, N. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07091.x · Cited by 338
Role of glycocalyx in leukocyte-endothelial cell adhesion
Mulivor, A. W., & Lipowsky, H. H. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00117.2002 · Cited by 328
Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559457 · Cited by 323
Margination of micro- and nano-particles in blood flow and its effect on drug delivery
Müller, K., Fedosov, D. A., & Gompper, G. (2014) · Scientific Reports · doi:10.1038/srep04871 · Cited by 312
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.050 · Cited by 311
Self-citationTurning Erythrocytes into Functional Micromotors
Wu, Z., Li, T., Li, J., Gao, W., Xu, T., Christianson, C., Gao, W., Galarnyk, M., He, Q., Zhang, L., et al. (2014) · ACS Nano · doi:10.1021/nn506200x · Cited by 310
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Fang, R. H., Hu, C.-M. J., Chen, K. N. H., Luk, B. T., Carpenter, C. W., Gao, W., Li, S., Zhang, D.-E., Lu, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr03064d · Cited by 302
The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges
Heathman, T. R., Nienow, A. W., McCall, M. J., Coopman, K., Kara, B., & Hewitt, C. J. (2015) · Regenerative Medicine · doi:10.2217/rme.14.73 · Cited by 297
(2012) · The Blood Group Antigen FactsBook · doi:10.1016/b978-0-12-415849-8.00051-x · Cited by 268
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 266
Peters, L. L., Shivdasani, R. A., Liu, S.-C., Hanspal, M., John, K. M., Gonzalez, J. M., Brugnara, C., Gwynn, B., Mohandas, N., Alper, S. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80167-1 · Cited by 261
Cell‐Membrane‐Coated Synthetic Nanomotors for Effective Biodetoxification
Wu, Z., Li, T., Gao, W., Xu, T., Jurado‐Sánchez, B., Li, J., Gao, W., He, Q., Zhang, L., & Wang, J. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501050 · Cited by 257
The effects of particle size, density and shape on margination of nanoparticles in microcirculation
Toy, R., Hayden, E., Shoup, C., Baskaran, H., & Karathanasis, E. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/11/115101 · Cited by 254
Wang, C., Sun, X., Cheng, L., Yin, S., Yang, G., Li, Y., & Liu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201400158 · Cited by 252
Panosyan, E. H., Seibel, N. L., Martin-Aragon, S., Gaynon, P. S., Avramis, I. A., Sather, H., Franklin, J., Nachman, J., Ettinger, L. J., La, M., et al. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200404000-00002 · Cited by 236
Zhang, J., Johnson, P. C., & Popel, A. S. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.01.010 · Cited by 219
Mollison's Blood Transfusion in Clinical Medicine
(2014) · Wiley eBooks · doi:10.1002/9781118689943 · Cited by 219
Carrier Erythrocytes: An Overview
Hamidi, M., & Tajerzadeh, H. (2003) · Drug Delivery · doi:10.1080/713840329 · Cited by 215
Erythrocyte Membrane-Cloaked Polymeric Nanoparticles for Controlled Drug Loading and Release
Aryal, S., Hu, C.-M. J., Fang, R. H., Dehaini, D., Carpenter, C., Zhang, D.-E., & Zhang, L. (2013) · Nanomedicine · doi:10.2217/nnm.12.153 · Cited by 214
The blood group antigen factsbook
Poole, J. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)84727-5 · Cited by 212
Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes
Shi, J., Kundrat, L., Pishesha, N., Bilate, A., Theile, C., Maruyama, T., Dougan, S. K., Ploegh, H. L., & Lodish, H. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409861111 · Cited by 209
Function of human Rh based on structure of RhCG at 2.1 Å
Gruswitz, F., Chaudhary, S., Ho, J. D., Schlessinger, A., Pezeshki, B., Ho, C.-M., Sali, A., Westhoff, C. M., & Stroud, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003587107 · Cited by 207
Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes
Chambers, E., & Mitragotri, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.005 · Cited by 206
Self-citationInfluence of red blood cells on nanoparticle targeted delivery in microcirculation
Tan, J., Thomas, A., & Liu, Y. (2012) · Soft Matter · doi:10.1039/c2sm06391c · Cited by 203
The structure and function of band 3 (AE1): Recent developments (Review)
Tanner, M. J. A. (1997) · Molecular Membrane Biology · doi:10.3109/09687689709048178 · Cited by 202
The influence of size, shape and vessel geometry on nanoparticle distribution
Tan, J., Shah, S., Thomas, A., Ou-Yang, H. D., & Liu, Y. (2013) · Microfluidics and Nanofluidics · doi:10.1007/s10404-012-1024-5 · Cited by 201
Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers
Charoenphol, P., Huang, R. B., & Eniola-Adefeso, O. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.007 · Cited by 191
Murciano, J.-C., Medinilla, S., Eslin, D., Atochina, E., Cines, D. B., & Muzykantov, V. R. (2003) · Nature Biotechnology · doi:10.1038/nbt846 · Cited by 190
Self-citationOn the near-wall accumulation of injectable particles in the microcirculation: smaller is not better
Lee, T.-R., Choi, M., Kopacz, A. M., Yun, S.-H., Liu, W. K., & Decuzzi, P. (2013) · Scientific Reports · doi:10.1038/srep02079 · Cited by 190
Engineering antigens for in situ erythrocyte binding induces T-cell deletion
Kontos, S., Kourtis, I. C., Dane, K. Y., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216353110 · Cited by 190
Red blood cell blood group antigens: structure and function
Reid, M. E., & Mohandas, N. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.01.001 · Cited by 187
Mechanism of Margination in Confined Flows of Blood and Other Multicomponent Suspensions
Kumar, A., & Graham, M. D. (2012) · Physical Review Letters · doi:10.1103/physrevlett.109.108102 · Cited by 185
Heddle, N. M., Soutar, R. L., O'Hoski, P. L., Singer, J., McBride, J. A., Ali, M. A. M., & Kelton, J. G. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05425.x · Cited by 176
Sosale, N. G., Rouhiparkouhi, T., Bradshaw, A. M., Dimova, R., Lipowsky, R., & Discher, D. E. (2014) · Blood · doi:10.1182/blood-2014-06-585299 · Cited by 161
Chessa, L., Leuzzi, V., Plebani, A., Soresina, A., Micheli, R., D’Agnano, D., Venturi, T., Molinaro, A., Fazzi, E. M., Marini, M., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-5 · Cited by 150
Nanoplasmonics for Dual-Molecule Release through Nanopores in the Membrane of Red Blood Cells
Delcea, M., Sternberg, N., Yashchenok, A. M., Georgieva, R. T., Bäumler, H., Möhwald, H., & Skirtach, A. G. (2012) · ACS Nano · doi:10.1021/nn3006619 · Cited by 146
Engineered nanoparticles mimicking cell membranes for toxin neutralization
Fang, R. H., Luk, B. T., Hu, C. J., & Zhang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.001 · Cited by 141
Gubin, A. N., Njoroge, J. M., Wojda, U., Pack, S., Rios, M., Reid, M. E., & Miller, J. L. (2000) · Blood · doi:10.1182/blood.v96.7.2621 · Cited by 139
Namdee, K., Thompson, A. J., Charoenphol, P., & Eniola‐Adefeso, O. (2013) · Langmuir · doi:10.1021/la304746p · Cited by 138
He, H., Ye, J., Wang, Y., Liu, Q., Chung, H. S., Kwon, Y. M., Shin, M. C., Lee, K., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.019 · Cited by 134
Erythrocyte engineering for drug delivery and targeting
Magnani, M., Rossi, L., D’Ascenzo, M., Panzani, I., Bigi, L., & Zanella, A. (1998) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1998.tb00505.x · Cited by 130
The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles
Merkel, T. J., Chen, K., Jones, S. W., Pandya, A., Tian, S., Napier, M. E., Zamboni, W. C., & DeSimone, J. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.009 · Cited by 123
Red blood cell deformability influences platelets--vessel wall interaction in flowing blood
Aarts, P. A. M. M., Heethaar, R. M., & Sixma, J. J. (1984) · Blood · doi:10.1182/blood.v64.6.1228.bloodjournal6461228 · Cited by 122
The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow
Thompson, A. J., Mastria, E. M., & Eniola‐Adefeso, O. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.011 · Cited by 122
Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo
Zennadi, R., Moeller, B. J., Whalen, E. J., Batchvarova, M., Xu, K., Shan, S., Delahunty, M. D., Dewhirst, M. W., & Telen, M. J. (2007) · Blood · doi:10.1182/blood-2006-11-056101 · Cited by 121
The margination propensity of spherical particles for vascular targeting in the microcirculation
Gentile, F., Curcio, A., Indolfi, C., Mauro Ferrari, B., & Decuzzi, P. (2008) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-6-9 · Cited by 120
Delivery of Drugs Bound to erythrocytes: New Avenues for an Old Intravascular Carrier
Villa, C. H., Pan, D. C., Zaitsev, S. V., Cines, D. B., Siegel, D. L., & Muzykantov, V. R. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.34 · Cited by 116
Self-citationSquishy Non‐Spherical Hydrogel Microparticles
Haghgooie, R., Toner, M., & Doyle, P. S. (2009) · Macromolecular Rapid Communications · doi:10.1002/marc.200900302 · Cited by 111
Anselmo, A. C., Kumar, S., Gupta, V., Pearce, A. M., Ragusa, A., Muzykantov, V. R., & Mitragotri, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.043 · Cited by 100
Self-citationZaitsev, S. V., Spitzer, D., Murciano, J.-C., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261610 · Cited by 99
MNS blood group system: a review
Reid, M. E. (2009) · Immunohematology · doi:10.21307/immunohematology-2019-240 · Cited by 99
Vahidkhah, K., & Bagchi, P. (2015) · Soft Matter · doi:10.1039/c4sm02686a · Cited by 93
Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase
Lorentz, K. M., Kontos, S., Diaceri, G., Henry, H., & Hubbell, J. A. (2015) · Science Advances · doi:10.1126/sciadv.1500112 · Cited by 93
Montel‐Hagen, A., Blanc, L., Boyer-Clavel, M., Jacquet, C., Vidal, M., Sitbon, M., & Taylor, N. N. (2008) · Blood · doi:10.1182/blood-2008-05-159269 · Cited by 91
Low Modulus Biomimetic Microgel Particles with High Loading of Hemoglobin
Chen, K., Merkel, T. J., Pandya, A., Napier, M. E., Luft, J. C., Daniel, W., Sheiko, S. S., & DeSimone, J. M. (2012) · Biomacromolecules · doi:10.1021/bm3007242 · Cited by 91
Kishnani, P. S., Dickson, P., Muldowney, L., Lee, J. J., Rosenberg, A. S., Abichandani, R., Bluestone, J. A., Burton, B. K., Dewey, M. C., Freitas, A., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.11.001 · Cited by 89
Moles, E., Urbán, P., Jiménez-Dı́az, M. B., Viera, S., Angulo‐Barturen, Í., Busquets, M. A., & Fernàndez‐Busquets, X. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.284 · Cited by 88
Sosa, J. M., Nielsen, N. D., Vignes, S. M., Chen, T. G., & Shevkoplyas, S. S. (2014) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-131719 · Cited by 88
International seminar on the red blood cells as vehicles for drugs
Godfrin, Y., Horand, F., Franco, R. S., Dufour, E., Kosenko, E. A., Bax, B. E., Banz, A., Skorokhod, O. A., Lanao, J. M., Vitvitsky, V., et al. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.631909 · Cited by 87
Antonelli, A., Sfara, C., Manuali, E., Bruce, I. J., & Magnani, M. (2011) · Nanomedicine · doi:10.2217/nnm.10.163 · Cited by 86
Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator
Danielyan, K. E., Ganguly, K., Ding, B., Atochin, D. N., Zaitsev, S. V., Murciano, J.-C., Huang, P. L., Kasner, S. E., Cines, D. B., & Muzykantov, V. R. (2008) · Circulation · doi:10.1161/circulationaha.107.750257 · Cited by 85
Self-citationBachet, J., Gay, F., Maréchal, R., Galais, M., Adenis, A., Salako, D., Cros, J. F., Demetter, P., Svrcek, M., Bardier–Dupas, A., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000394 · Cited by 83
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
Grimm, A. J., Kontos, S., Diaceri, G., Quaglia-Thermes, X., & Hubbell, J. A. (2015) · Scientific Reports · doi:10.1038/srep15907 · Cited by 82
Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models
Ryder, A. B., Zimring, J. C., & Hendrickson, J. E. (2014) · Transfusion Medicine and Hemotherapy · doi:10.1159/000368995 · Cited by 80
Hunault, M., Leguay, T., Huguet, F., Leprêtre, S., Deconinck, É., Ojeda‐Uribe, M., Bonmati, C., Escoffre‐Barbe, M., Bories, P., Himberlin, C., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.24093 · Cited by 79
Glycosaminoglycans in the cellular uptake of drug delivery vectors – Bystanders or active players?
Favretto, M. E., Wallbrecher, R., Schmidt, S., van de Putte, R., & Brock, R. E. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.02.011 · Cited by 78
Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging
Ahn, S., Jung, S. Y., Seo, E., & Lee, S. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.023 · Cited by 77
D’Apolito, R., Tomaiuolo, G., Taraballi, F., Minardi, S., Kirui, D. K., Liu, X., Cevenini, A., Palomba, R., Ferrari, M., Salvatore, F., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.013 · Cited by 76
Marques, J., Moles, E., Urbán, P., Prohens, R., Busquets, M. A., Sevrin, C., Grandfils, C., & Fernàndez‐Busquets, X. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.06.002 · Cited by 76
Calderon, A. J., Bhowmick, T. K., Leferovich, J. M., Burman, B., Pichette, B., Muzykantov, V. R., Eckmann, D. M., & Muro, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.025 · Cited by 74
Self-citationNon-affinity factors modulating vascular targeting of nano- and microcarriers
Myerson, J. W., Anselmo, A. C., Liu, Y., Mitragotri, S., Eckmann, D. M., & Muzykantov, V. R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.011 · Cited by 73
Self-citationRed cell-derived microparticles (RMP) as haemostatic agent
Johansen, M. E., Bidot, C., Horstman, L. L., Ahn, Y. S., & Jy, W. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-12-0941 · Cited by 71
Zaitsev, S. V., Kowalska, M. A., Neyman, M., Carnemolla, R., Tliba, S., Ding, B., Stonestrom, A. J., Spitzer, D., Atkinson, J. P., Poncz, M., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398149 · Cited by 68
Self-citationLejeune, A., Moorjani, M., Gicquaud, C., et al. (1994) · PubMed · Cited by 68
Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells
Calderon, A. J., Muzykantov, V. R., Muro, S., & Eckmann, D. M. (2009) · Biorheology · doi:10.3233/bir-2009-0544 · Cited by 66
Self-citationZaitsev, S. V., Danielyan, K. E., Murciano, J.-C., Ganguly, K., Krasik, T., Taylor, R. P., Pincus, S., Jones, S. M., Cines, D. B., & Muzykantov, V. R. (2006) · Blood · doi:10.1182/blood-2005-11-012336 · Cited by 65
Self-citationLindorfer, M. A., Hahn, C. S., Foley, P. L., & Taylor, R. P. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1830102.x · Cited by 63
Favretto, M. E., Cluitmans, J. C. A., Bosman, G. J. C. G. M., & Brock, R. E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.032 · Cited by 62
Approaches to erythrocyte-mediated drug delivery
Magnani, M., & Rossi, L. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.889679 · Cited by 62
Muzykantov, V. R., Murciano, J.-C., Taylor, R. P., et al. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0384 · Cited by 61
Self-citationShellington, D. K., Du, L., Wu, X., Exo, J. L., Vagni, V., Ma, L., Janesko‐Feldman, K. L., Clark, R. S. B., Bayır, H., Dixon, C. E., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206b1fa · Cited by 60
Atukorale, P. U., Yang, Y.-S. S., Bekdemir, A., Carney, R. P., Silva, P. J., Watson, N., Stellacci, F., & Irvine, D. J. (2015) · Nanoscale · doi:10.1039/c5nr01355k · Cited by 60
Gubin, A. N., Njoroge, J. M., Wojda, U., et al. (2000) · PubMed · Cited by 59
Perturbation of red blood cell membrane rigidity by extracellular ligands
Paulitschke, M., Nash, G. B., Anstee, D., et al. (1995) · Blood · doi:10.1182/blood.v86.1.342.bloodjournal861342 · Cited by 56
Hamidi, M., Rafiei, P., Azadi, A., & Mohammadi‐Samani, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22395 · Cited by 56
Murciano, J.-C., Higazi, A. A., Cines, D. B., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.07.003 · Cited by 56
ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement
Spitzer, D. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.017 · Cited by 54
Ex-vivo generation of human red cells for transfusion
Anstee, D. J., Gampel, A., & Toye, A. M. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328352240a · Cited by 53
Hill, A., Ridley, S. H., Esser, D., Oldroyd, R. G., Cullen, M. J., Kareclas, P., Gallagher, S., Smith, G. P., Richards, S. J., White, J., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0782 · Cited by 53
Taylor, R. P., Sutherland, W. M., Reist, C. J., Webb, D. J., Wright, E. L., & Labuguen, R. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3305 · Cited by 52
Immunotargeting of erythrocytes-bound streptokinase provides local lysis of a fibrin clot
Muzykantov, V. R., Sakharov, D. V., Smirnov, M. D., Samokhin, G. P., & Smirnov, V. N. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90184-4 · Cited by 51
Self-citationHuang, X., Shah, S., Wang, J., Ye, Z., Dowey, S. N., Tsang, K. M., Mendelsohn, L. G., Kato, G. J., Kickler, T. S., & Cheng, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.201 · Cited by 51
Asher, D. R., Cerny, A., & Finberg, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506211102 · Cited by 50
Staedtke, V., Brähler, M., Müller, A., Georgieva, R. T., Bauer, S., Sternberg, N., Voigt, A., Lemke, A., Keck, C. M., Möschwitzer, J. P., et al. (2009) · Small · doi:10.1002/smll.200900919 · Cited by 49
Mukthavaram, R., Shi, G., Kesari, S., & Simberg, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.038 · Cited by 49
Immune Adherence Revisited: Novel Players in an Old Game
Hess, C., & Schifferli, J. A. (2003) · Physiology · doi:10.1152/nips.01425.2002 · Cited by 49
Chen, K., Xu, J., Luft, J. C., Tian, S., Raval, J. S., & DeSimone, J. M. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503939n · Cited by 49
Shi, G., Mukthavaram, R., Kesari, S., & Simberg, D. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300084 · Cited by 48
Greineder, C. F., Chacko, A., Zaitsev, S. V., Zern, B. J., Carnemolla, R., Hood, E. D., Han, J., Ding, B., Esmon, C. T., & Muzykantov, V. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080110 · Cited by 47
Self-citationZaltzman, A. B., van den Berg, C. W., Muzykantov, V. R., et al. (1995) · Biochemical Journal · doi:10.1042/bj3070651 · Cited by 46
Self-citationOrekhova, N. M., Akchurin, R. S., Belyaev, A. A., Smirnov, M. D., Ragimov, S. E., & Orekhov, A. N. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90078-q · Cited by 46
Red Cell-Mediated Therapy: Opportunities and Challenges
Krantz, A. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0119 · Cited by 44
Targeting of Pseudomonas aeruginosa in the Bloodstream with Bispecific Monoclonal Antibodies
Lindorfer, M. A., Nardin, A., Foley, P. L., Solga, M. D., Bankovich, A. J., Martin, E. N., Henderson, A. L., Price, C. W., Gyimesi, E., Wozencraft, C. P., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2240 · Cited by 43
Oudin, S., Libyh, M. T., Goossens, D., Dervillez, X., Philbert, F., Réveil, B., Bougy, F., Tabary, T., Rouger, P., Klatzmann, D., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1505 · Cited by 42
Armstead, W. M., Ganguly, K., Kiessling, J. W., Riley, J., Chen, X., Smith, D. H., Stein, S. C., Higazi, A. A., Cines, D. B., Bdeir, K. H., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06613.x · Cited by 41
Self-citationImproving Protein Pharmacokinetics by Engineering Erythrocyte Affinity
Kontos, S., & Hubbell, J. A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001697 · Cited by 40
Characterization of nanoparticle delivery in microcirculation using a microfluidic device
Thomas, A., Tan, J., & Liu, Y. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.04.008 · Cited by 40
Muzykantov, V. R., Sakharov, D. V., Domogatsky, S. P., Goncharov, N. V., & Danilov, S. M. (1987) · PubMed · Cited by 39
Self-citationIdentification of Peptide Ligands Facilitating Nanoparticle Attachment to Erythrocytes
Hall, S. S., Mitragotri, S., & Daugherty, P. S. (2007) · Biotechnology Progress · doi:10.1021/bp060333l · Cited by 38
Self-citationPickens, B., Mao, Y., Li, D., Siegel, D. L., Poncz, M., Cines, D. B., & Zheng, X. L. (2015) · Blood · doi:10.1182/blood-2014-07-587139 · Cited by 37
Craig, M. L., Waitumbi, J. N., & Taylor, R. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3059 · Cited by 37
Ganguly, K., Goel, M. S., Krasik, T., Bdeir, K. H., Diamond, S. L., Cines, D. B., Muzykantov, V. R., & Murciano, J.-C. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093450 · Cited by 34
Self-citationMai, T. D., d’Orlyé, F., Ménager, C., Varenne, A., & Siaugue, J. (2013) · Chemical Communications · doi:10.1039/c3cc41513a · Cited by 33
Immunogenicity of therapeutics: a matter of efficacy and safety
Nechansky, A., & Kircheis, R. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.514326 · Cited by 32
Kuhn, S., Nardin, A., Klebba, P. E., & Taylor, R. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5088 · Cited by 28
Targeting of enzyme immobilized on erythrocyte membrane to collagen‐coated surface
Muzykantov, V. R., Sakharov, D. V., Smirnov, M. D., Domogatsky, S. P., & Samokhin, G. P. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)81154-6 · Cited by 27
Self-citationImmunospecific targeting of immunoliposomes, F(ab′)2 and IgG to red blood cells in vivo
Peeters, P. A. M., Oussoren, C., Eling, W. M. C., & Crommelin, D. J. A. (1988) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(88)90545-7 · Cited by 26
War and peace: Factor VIII and the adaptive immune response
Georgescu, M. T., Lai, J. D., Hough, C. A., & Lillicrap, D. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.11.008 · Cited by 21
(2007) · PubMed
Cited by
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Self-citationTargeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Self-citationSoft erythrocyte-based bacterial microswimmers for cargo delivery
Alapan, Y., Yasa, O., Schauer, O., Giltinan, J., Tabak, A. F., Sourjik, V., & Sitti, M. (2018) · Science Robotics · doi:10.1126/scirobotics.aar4423 · Cited by 420
Jiang, Q., Liu, Y., Guo, R., Yao, X., Sung, S., Pang, Z., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.021 · Cited by 398
Pei, Q., Hu, X., Zheng, X., Liu, S., Li, Y., Jing, X., & Xie, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b08219 · Cited by 366
Metadata
- Authors
- Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 106
- Issue
- Pt A
- Pages
- 88-103
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2290569047
- Cited by
- 397
- References
- 157
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.